Blumenthal Cancer Center at Carolinas Medical Center
4 clinical trials · Sponsor
◉ Watch Blumenthal Cancer Center at Carolinas Medical Center
| Record | Firm | Date |
|---|---|---|
| High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 (NCT00080977) | Blumenthal Cancer Center at Carolinas Medical Center | 1998-06-01 |
| Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer (NCT00002846) | Blumenthal Cancer Center at Carolinas Medical Center | 1995-09-01 |
| Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00002845) | Blumenthal Cancer Center at Carolinas Medical Center | 1995-09-01 |
| Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer (NCT00002847) | Blumenthal Cancer Center at Carolinas Medical Center | 1995-09-01 |
Track Blumenthal Cancer Center at Carolinas Medical Center automatically
Every clearance here is in the API, with alerts when new ones post.